title: Probable rofecoxib-induced thrombocytopenia.
authors.forename: A
authors.initials: A
authors.lastname: Kentos
authors.forename: V
authors.initials: V
authors.lastname: Robin
authors.forename: M
authors.initials: M
authors.lastname: Lambermont
authors.forename: M
authors.initials: M
authors.lastname: Jurdan
authors.forename: M
authors.initials: M
authors.lastname: Pignarelli
authors.forename: W
authors.initials: W
authors.lastname: Feremans
mesh_terms: D000368:Aged; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D051546:Cyclooxygenase 2; D052246:Cyclooxygenase 2 Inhibitors; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects*; D006801:Humans; D007527:Isoenzymes / Q000037:antagonists & inhibitors; D007783:Lactones / Q000009:adverse effects*; D008297:Male; D008565:Membrane Proteins; D011451:Prostaglandin-Endoperoxide Synthases; D013450:Sulfones; D013921:Thrombocytopenia / Q000139:chemically induced*
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D052246:Cyclooxygenase 2 Inhibitors; D016861:Cyclooxygenase Inhibitors; D007527:Isoenzymes; D007783:Lactones; D008565:Membrane Proteins; D013450:Sulfones; C116926:rofecoxib; D051546:Cyclooxygenase 2; C496540:PTGS2 protein, human; D011451:Prostaglandin-Endoperoxide Synthases